From immunodeficiency to humanization: The contribution of mouse models to explore HTLV-1 leukemogenesis

Viruses

Volumn 7, Issue 12, 2015, Pages 6371-6386

  Pérès, Eléonore ^a,b   Bagdassarian, Eugénie ^a,b   This, Sébastien ^a,b   Villaudy, Julien ^c,d   Rigal, Dominique ^e   Gazzolo, Louis ^a,b   Dodon, Madeleine Duc ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b University Lyon i   (France)

^c AIMM Therapeutics   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Adult T cell leukemia lymphoma; HTLV 1; Humanized mouse models; Oncogenesis

Indexed keywords

APOPTOSIS; CELL MATURATION; CELL PROLIFERATION; DNA DAMAGE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNE DEFICIENCY; LEUKEMOGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RNA STABILITY; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS PATHOGENESIS; XENOGRAFT; ANIMAL; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; PATHOLOGY; SCID MOUSE; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MICE, SCID;

EID: 84949509653     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122944     Document Type: Review

References (93)

1. Baltimore, D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970, 226, 1209-1211. [CrossRef] [PubMed]
2. Temin, H.M.; Mizutani, S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970, 226, 1211-1213. [CrossRef] [PubMed]
3. Poiesz, B.J.; Ruscetti, F.W.; Gazdar, A.F.; Bunn, P.A.; Minna, J.D.; Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77, 7415-7419. [CrossRef] [PubMed]
4. Barre-Sinoussi, F.; Chermann, J.C.; Rey, F.; Nugeyre, M.T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Vezinet-Brun, F.; Rouzioux, C.; et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220, 868-871. [CrossRef] [PubMed]
5. Ito, R.; Takahashi, T.; Katano, I.; Ito, M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9, 208-214. [CrossRef] [PubMed]
6. Rongvaux, A.; Takizawa, H.; Strowig, T.; Willinger, T.; Eynon, E.E.; Flavell, R.A.; Manz, M.G. Human hemato-lymphoid system mice: Current use and future potential for medicine. Annu. Rev. Immunol. 2013, 31, 635-674. [CrossRef] [PubMed]
7. Shultz, L.D.; Brehm, M.A.; Garcia-Martinez, J.V.; Greiner, D.L. Humanized mice for immune system investigation: Progress, promise and challenges. Nat. Rev. Immunol. 2012, 12, 786-798. [CrossRef] [PubMed]
8. Akkina, R. New generation humanized mice for virus research: Comparative aspects and future prospects. Virology 2013, 435, 14-28. [CrossRef] [PubMed]
9. Duc Dodon, M.; Villaudy, J.; Gazzolo, L.; Haines, R.; Lairmore, M. What we are learning on HTLV-1 pathogenesis from animal models. Front. Microbiol. 2012, 3. [CrossRef] [PubMed]
10. Zimmerman, B.; Niewiesk, S.; Lairmore, M.D. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma. Vet. Pathol. 2010, 47, 677-689. [CrossRef] [PubMed]
11. Panfil, A.R.; Al-Saleem, J.J.; Green, P.L. Animal models utilized in HTLV-1 research. Virol. Res. Treat. 2013, 4, 49-59.
12. Takatsuki, K. Discovery of adult T-cell leukemia. Retrovirology 2005, 2. [CrossRef] [PubMed]
13. Proietti, F.A.; Carneiro-Proietti, A.B.; Catalan-Soares, B.C.; Murphy, E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24, 6058-6068. [CrossRef] [PubMed]
14. Yoshida, M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005, 24, 5931-5937. [CrossRef] [PubMed]
15. Kohno, T.; Yamada, Y.; Akamatsu, N.; Kamihira, S.; Imaizumi, Y.; Tomonaga, M.; Matsuyama, T. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 2005, 96, 527-533. [CrossRef] [PubMed]
16. Toulza, F.; Heaps, A.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: Inverse correlation with HTLV-1-specific CTL response. Blood 2008, 111, 5047-5053. [CrossRef] [PubMed]
17. Rowan, A.G.; Bangham, C.R. Is there a role for HTLV-1-specific CTL in adult T-cell leukemia/lymphoma? Leuk. Res. Treat. 2012. [CrossRef] [PubMed]
18. Uozumi, K. Treatment of adult T-cell leukemia. J. Clin. Exp. Hematopathol. 2010, 50, 9-25. [CrossRef]
19. Utsunomiya, A.; Choi, I.; Chihara, D.; Seto, M. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015, 106, 344-351. [CrossRef] [PubMed]
20. Matsuoka, M.; Jeang, K.T. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: Viral infectivity, Tax, HBZ and therapy. Oncogene 2011, 30, 1379-1389. [CrossRef] [PubMed]
21. Gaudray, G.; Gachon, F.; Basbous, J.; Biard-Piechaczyk, M.; Devaux, C.; Mesnard, J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76, 12813-12822. [CrossRef] [PubMed]
22. Barbeau, B.; Mesnard, J.M. Does chronic infection in retroviruses have a sense? Trends Microbiol. 2015, 23, 367-375. [CrossRef] [PubMed]
23. Lodewick, J.; Lamsoul, I.; Bex, F. Move or die: The fate of the Tax oncoprotein of HTLV-1. Viruses 2011, 3, 829-857. [CrossRef] [PubMed]
24. Matsuoka, M.; Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280. [CrossRef] [PubMed]
25. Coscoy, L.; Gonzalez-Dunia, D.; Tangy, F.; Syan, S.; Brahic, M.; Ozden, S. Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene. Virology 1998, 248, 332-341. [CrossRef] [PubMed]
26. Grossman,W.J.; Kimata, J.T.;Wong, F.H.; Zutter, M.; Ley, T.J.; Ratner, L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 1995, 92, 1057-1061. [CrossRef] [PubMed]
27. Hasegawa, H.; Sawa, H.; Lewis, M.J.; Orba, Y.; Sheehy, N.; Yamamoto, Y.; Ichinohe, T.; Katano, H.; Tsunetsugu-Yokota, Y.; Takahashi, H.; et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12, 466-472. [CrossRef] [PubMed]
28. Yamazaki, J.; Mizukami, T.; Takizawa, K.; Kuramitsu, M.; Momose, H.; Masumi, A.; Ami, Y.; Hasegawa, H.; Hall, W.W.; Tsujimoto, H.; et al. Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma. Blood 2009, 114, 2709-2720. [CrossRef] [PubMed]
29. Satou, Y.; Yasunaga, J.; Yoshida, M.; Matsuoka, M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 2006, 103, 720-725. [CrossRef] [PubMed]
30. Hagiya, K.; Yasunaga, J.; Satou, Y.; Ohshima, K.; Matsuoka, M. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011, 8. [CrossRef] [PubMed]
31. Lemasson, I.; Lewis, M.R.; Polakowski, N.; Hivin, P.; Cavanagh, M.H.; Thebault, S.; Barbeau, B.; Nyborg, J.K.; Mesnard, J.M. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 2007, 81, 1543-1553. [CrossRef] [PubMed]
32. Mitobe, Y.; Yasunaga, J.I.; Furuta, R.; Matsuoka, M. HTLV-1 bZIP factor RNA and protein impart distinct functions on T-cell proliferation and survival. Cancer Res. 2015, 75, 4143-4152. [CrossRef] [PubMed]
33. Borowiak, M.; Kuhlmann, A.S.; Girard, S.; Gazzolo, L.; Mesnard, J.M.; Jalinot, P.; Duc Dodon, M. HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene. Carcinogenesis 2013, 34, 2664-2672. [CrossRef] [PubMed]
34. Kuhlmann, A.S.; Villaudy, J.; Gazzolo, L.; Castellazzi, M.; Mesnard, J.M.; Duc Dodon, M. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007, 4. [CrossRef] [PubMed]
35. Satou, Y.; Yasunaga, J.; Zhao, T.; Yoshida, M.; Miyazato, P.; Takai, K.; Shimizu, K.; Ohshima, K.; Green, P.L.; Ohkura, N.; et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7, e1001274. [CrossRef] [PubMed]
36. Zhao, T.; Yasunaga, J.; Satou, Y.; Nakao, M.; Takahashi, M.; Fujii, M.; Matsuoka, M. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kB. Blood 2009, 113, 2755-2764. [CrossRef] [PubMed]
37. Tanaka-Nakanishi, A.; Yasunaga, J.; Takai, K.; Matsuoka, M. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization. Cancer Res. 2014, 74, 188-200. [CrossRef] [PubMed]
38. Arnold, J.; Zimmerman, B.; Li, M.; Lairmore, M.D.; Green, P.L. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008, 112, 3788-3797. [CrossRef] [PubMed]
39. Yamamoto-Taguchi, N.; Satou, Y.; Miyazato, P.; Ohshima, K.; Nakagawa, M.; Katagiri, K.; Kinashi, T.; Matsuoka, M. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013, 9, e1003630. [CrossRef] [PubMed]
40. Mitagami, Y.; Yasunaga, J.I.; Kinosada, H.; Ohshima, K.; Matsuoka, M. Interferon-gamma promotes inflammation and development of T-cell lymphoma in HTLV-1 bZIP factor transgenic mice. PLoS Pathog. 2015, 11, e1005120. [CrossRef] [PubMed]
41. Zhao, T.; Satou, Y.; Matsuoka, M. Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice. Arch. Virol. 2014, 159, 1849-1856. [CrossRef] [PubMed]
42. Ohsugi, T. A transgenic mouse model of human T cell leukemia virus type 1-associated diseases. Front. Microbiol. 2013, 4. [CrossRef] [PubMed]
43. Nerenberg, M.; Hinrichs, S.H.; Reynolds, R.K.; Khoury, G.; Jay, G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987, 237, 1324-1329. [CrossRef] [PubMed]
44. Furuta, Y.; Aizawa, S.; Suda, Y.; Ikawa, Y.; Kishimoto, H.; Asano, Y.; Tada, T.; Hikikoshi, A.; Yoshida, M.; Seiki, M. Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I. J. Virol. 1989, 63, 3185-3189. [PubMed]
45. Ruddle, N.H.; Li, C.B.; Horne,W.C.; Santiago, P.; Troiano, N.; Jay, G.; Horowitz, M.; Baron, R. Mice transgenic for HTLV-I LTR-tax exhibit tax expression in bone, skeletal alterations, and high bone turnover. Virology 1993, 197, 196-204. [CrossRef] [PubMed]
46. Rauch, D.A.; Ratner, L. Targeting HTLV-1 activation of NFkB in mouse models and ATLL patients. Viruses 2011, 3, 886-900. [CrossRef] [PubMed]
47. Rauch, D.; Gross, S.; Harding, J.; Niewiesk, S.; Lairmore, M.; Piwnica-Worms, D.; Ratner, L. Imaging spontaneous tumorigenesis: Inflammation precedes development of peripheral NK tumors. Blood 2009, 113, 1493-1500. [CrossRef] [PubMed]
48. Thebault, S.; Basbous, J.; Hivin, P.; Devaux, C.; Mesnard, J.M. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 2004, 562, 165-170. [CrossRef]
49. Sugata, K.; Satou, Y.; Yasunaga, J.; Hara, H.; Ohshima, K.; Utsunomiya, A.; Mitsuyama, M.; Matsuoka, M. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 2012, 119, 434-444. [CrossRef] [PubMed]
50. Sugata, K.; Yasunaga, J.I.; Mitobe, Y.; Miura, M.; Miyazato, P.; Kohara, M.; Matsuoka, M. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. Blood 2015, 126, 1095-1105. [CrossRef] [PubMed]
51. Flanagan, S.P. "Nude", a new hairless gene with pleiotropic effects in the mouse. Genet. Res. 1966, 8, 295-309. [CrossRef] [PubMed]
52. Bosma, G.C.; Custer, R.P.; Bosma, M.J. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301, 527-530. [CrossRef] [PubMed]
53. Shultz, L.D.; Schweitzer, P.A.; Christianson, S.W.; Gott, B.; Schweitzer, I.B.; Tennent, B.; McKenna, S.; Mobraaten, L.; Rajan, T.V.; Greiner, D.L.; et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 1995, 154, 180-191. [PubMed]
54. Traggiai, E.; Chicha, L.; Mazzucchelli, L.; Bronz, L.; Piffaretti, J.C.; Lanzavecchia, A.; Manz, M.G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304, 104-107. [CrossRef] [PubMed]
55. Parrula, C.; Zimmerman, B.; Nadella, P.; Shu, S.; Rosol, T.; Fernandez, S.; Lairmore, M.; Niewiesk, S. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009, 46, 1003-1014. [CrossRef] [PubMed]
56. Nagai, Y.; Kawahara, M.; Hishizawa, M.; Shimazu, Y.; Sugino, N.; Fujii, S.; Kadowaki, N.; Takaori-Kondo, A. T memory stem cells are the hierarchical apex of adult T-cell leukemia. Blood 2015, 125, 3527-3535. [CrossRef] [PubMed]
57. Feuer, G.; Fraser, J.K.; Zack, J.A.; Lee, F.; Feuer, R.; Chen, I.S. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: Maintenance of virus infection during differentiation in vitro and in vivo. J. Virol. 1996, 70, 4038-4044. [PubMed]
58. Villaudy, J.; Wencker, M.; Gadot, N.; Gillet, N.A.; Scoazec, J.Y.; Gazzolo, L.; Manz, M.G.; Bangham, C.R.; Duc Dodon, M. HTLV-1 propels thymic human T cell development in "human immune system" Rag2/ gamma c/ mice. PLoS Pathog. 2011, 7, e1002231. [CrossRef] [PubMed]
59. Tezuka, K.; Xun, R.; Tei, M.; Ueno, T.; Tanaka, M.; Takenouchi, N.; Fujisawa, J. An animal model of adult T-cell leukemia: Humanized mice with HTLV-1-specific immunity. Blood 2014, 123, 346-355. [CrossRef] [PubMed]
60. Mosier, D.E.; Gulizia, R.J.; Baird, S.M.;Wilson, D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335, 256-259. [CrossRef] [PubMed]
61. Namikawa, R.; Weilbaecher, K.N.; Kaneshima, H.; Yee, E.J.; McCune, J.M. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 1990, 172, 1055-1063. [CrossRef] [PubMed]
62. McCune, J.M.; Namikawa, R.; Shih, C.C.; Rabin, L.; Kaneshima, H. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 1990, 247, 564-566. [CrossRef] [PubMed]
63. Melkus, M.W.; Estes, J.D.; Padgett-Thomas, A.; Gatlin, J.; Denton, P.W.; Othieno, F.A.;Wege, A.K.; Haase, A.T.; Garcia, J.V. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12, 1316-1322. [CrossRef] [PubMed]
64. Ishikawa, F.; Yasukawa, M.; Lyons, B.; Yoshida, S.; Miyamoto, T.; Yoshimoto, G.;Watanabe, T.; Akashi, K.; Shultz, L.D.; Harada, M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor chainnull mice. Blood 2005, 106, 1565-1573. [CrossRef] [PubMed]
65. Ito, M.; Kobayashi, K.; Nakahata, T. NOD/Shi-scid IL2rnull (NOG) mice more appropriate for humanized mouse models. Curr. Top. Microbiol. Immunol. 2008, 324, 53-76. [PubMed]
66. Rongvaux, A.; Willinger, T.; Martinek, J.; Strowig, T.; Gearty, S.V.; Teichmann, L.L.; Saito, Y.; Marches, F.; Halene, S.; Palucka, A.K.; et al. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechnol. 2014, 32, 364-372. [CrossRef] [PubMed]
67. Cao, X.; Shores, E.W.; Hu-Li, J.; Anver, M.R.; Kelsall, B.L.; Russell, S.M.; Drago, J.; Noguchi, M.; Grinberg, A.; Bloom, E.T.; et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2, 223-238. [CrossRef]
68. Brehm, M.A.; Wiles, M.V.; Greiner, D.L.; Shultz, L.D. Generation of improved humanized mouse models for human infectious diseases. J. Immunol. Methods 2014, 410, 3-17. [CrossRef] [PubMed]
69. Cachat, A.; Villaudy, J.; Rigal, D.; Gazzolo, L.; Duc Dodon, M. Mice are not Men and yet… how humanized mice inform us about human infectious diseases. Med. Sci. 2012, 28, 63-68.
70. Legrand, N.; Huntington, N.D.; Nagasawa, M.; Bakker, A.Q.; Schotte, R.; Strick-Marchand, H.; de Geus, S.J.; Pouw, S.M.; Bohne, M.; Voordouw, A.; et al. Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T-and natural killer-(NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. USA 2011, 108, 13224-13229. [CrossRef] [PubMed]
71. Brehm, M.A.; Cuthbert, A.; Yang, C.; Miller, D.M.; Dilorio, P.; Laning, J.; Burzenski, L.; Gott, B.; Foreman, O.; Kavirayani, A.; et al. Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rnull mutation. Clin. Immunol. 2010, 135, 84-98. [CrossRef] [PubMed]
72. Takenaka, K.; Prasolava, T.K.;Wang, J.C.; Mortin-Toth, S.M.; Khalouei, S.; Gan, O.I.; Dick, J.E.; Danska, J.S. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 2007, 8, 1313-1323. [CrossRef] [PubMed]
73. Liu, Y.; Dole, K.; Stanley, J.R.; Richard, V.; Rosol, T.J.; Ratner, L.; Lairmore, M.; Feuer, G. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leuk. Res. 2002, 26, 561-567. [CrossRef]
74. Takajo, I.; Umeki, K.; Morishita, K.; Yamamoto, I.; Kubuki, Y.; Hatakeyama, K.; Kataoka, H.; Okayama, A. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/null (NOG) mice. Int. J. Cancer 2007, 121, 2205-2211. [CrossRef] [PubMed]
75. Kawano, N.; Ishikawa, F.; Shimoda, K.; Yasukawa, M.; Nagafuji, K.; Miyamoto, T.; Baba, E.; Tanaka, T.; Yamasaki, S.; Gondo, H.; et al. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/α2-microglobulinnull mice. Leukemia 2005, 19, 1384-1390. [CrossRef] [PubMed]
76. Jones, K.S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F.W.; Hermine, O.; Pique, C. Molecular aspects of HTLV-1 entry: Functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses 2011, 3, 794-810. [CrossRef] [PubMed]
77. Uota, S.; Zahidunnabi Dewan, M.; Saitoh, Y.; Muto, S.; Itai, A.; Utsunomiya, A.; Watanabe, T.; Yamamoto, N.; Yamaoka, S. An IkB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells. Cancer Sci. 2012, 103, 100-106. [CrossRef] [PubMed]
78. Satou, Y.; Nosaka, K.; Koya, Y.; Yasunaga, J.I.; Toyokuni, S.; Matsuoka, M. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 2004, 18, 1357-1363. [CrossRef] [PubMed]
79. Ishitsuka, K.; Kunami, N.; Katsuya, H.; Nogami, R.; Ishikawa, C.; Yotsumoto, F.; Tanji, H.; Mori, N.; Takeshita, M.; Miyamoto, S.; et al. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737. Cancer Lett. 2012, 317, 218-225. [CrossRef] [PubMed]
80. Hisatomi, T.; Sueoka-Aragane, N.; Sato, A.; Tomimasu, R.; Ide, M.; Kurimasa, A.; Okamoto, K.; Kimura, S.; Sueoka, E. NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase IIα and DNA-dependent protein kinase. Blood 2011, 117, 3575-3584. [CrossRef] [PubMed]
81. Parrula, C.; Fernandez, S.A.; Zimmerman, B.; Lairmore, M.; Niewiesk, S. Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma. J. Gen. Virol. 2011, 92, 1458-1466. [CrossRef] [PubMed]
82. Ito, A.; Ishida, T.; Utsunomiya, A.; Sato, F.; Mori, F.; Yano, H.; Inagaki, A.; Suzuki, S.; Takino, H.; Ri, M.; et al. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R null mice in vivo. J. Immunol. 2009, 183, 4782-4791. [CrossRef] [PubMed]
83. Maeda, N.; Muta, H.; Oflazoglu, E.; Yoshikai, Y. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo. Cancer Sci. 2010, 101, 224-230. [CrossRef] [PubMed]
84. Bangham, C.R. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 2009, 39, 1700-1712. [CrossRef] [PubMed]
85. Banerjee, P.; Crawford, L.; Samuelson, E.; Feuer, G. Hematopoietic stem cells and retroviral infection. Retrovirology 2010, 7. [CrossRef] [PubMed]
86. Wencker, M.; Gazzolo, L.; Duc Dodon, M. The leukemogenic activity of Tax HTLV-1 during αβ T cell development. Front. Biosci. 2009, 1, 194-204. [CrossRef]
87. El Hajj, H.; El-Sabban, M.; Hasegawa, H.; Zaatari, G.; Ablain, J.; Saab, S.T.; Janin, A.; Mahfouz, R.; Nasr, R.; Kfoury, Y.; et al. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J. Exp. Med. 2010, 207, 2785-2792. [CrossRef] [PubMed]
88. Centlivre, M.; Legrand, N.; Berkhout, B. A conditionally replicating human immunodeficiency virus in BRG-HIS mice. In Humanized Mice for HIV Research; Polakowski, N., Garcia, J.V., Koyanagi, Y., Manz, M.G., Tager, A.M., Eds.; Springer: New York, NY, USA, 2014; pp. 443-454.
89. Martin-Latil, S.; Gnadig, N.F.; Mallet, A.; Desdouits, M.; Guivel-Benhassine, F.; Jeannin, P.; Prevost, M.C.; Schwartz, O.; Gessain, A.; Ozden, S.; et al. Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells. Blood 2012, 120, 572-580. [CrossRef] [PubMed]
90. Shultz, L.D.; Saito, Y.; Najima, Y.; Tanaka, S.; Ochi, T.; Tomizawa, M.; Doi, T.; Sone, A.; Suzuki, N.; Fujiwara, H.; et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r null humanized mice. Proc. Natl. Acad. Sci. USA 2010, 107, 13022-13027. [CrossRef] [PubMed]
91. Suzuki, M.; Takahashi, T.; Katano, I.; Ito, R.; Ito, M.; Harigae, H.; Ishii, N.; Sugamura, K. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/gammacnull mouse. Int. Immunol. 2012, 24, 243-252. [CrossRef] [PubMed]
92. Yang, H.;Wang, H.; Shivalila, C.S.; Cheng, A.W.; Shi, L.; Jaenisch, R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013, 154, 1370-1379. [CrossRef] [PubMed]
93. Grupp, S.A. Advances in T-cell therapy for ALL. Best Pract. Res. Clin. Haematol. 2014, 27, 222-228. [CrossRef] [PubMed]